300962 Zhongjin Irradiation Incorporated
- 15.09
- -0.28-1.82%
Zhongjin Irradiation Incorporated News
CICC Radiation (300962.SZ): Net profit of 298.36 million yuan in the first quarter increased 1.82% year-on-year
On April 26, CICC Radiation (300962.SZ) released its first quarter report. Operating revenue was 83.62 million yuan, up 4.09% year on year, net profit of 298.36 million yuan, up 1.82% year on year, after deducting non-net profit of 29.13 million yuan, up 2.06% year on year, with basic earnings of 0.1,130 yuan per share.
CICC Irradiation (300962.SZ) shareholders Xinwei and Xingang reduced their holdings by a total of 1.185,300 shares at the end of the reduction period
CICC Radiation (300962.SZ) announced that the company received Gongqingcheng Xinwei Investment Management Partnership (Limited Partnership)...
Zhongjin Irradiation Incorporated Company (SZSE:300962) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Zhongjin Irradiation Incorporated Company (SZSE:300962) shareholders have had their patience rewarded with a 26% share price jump in the last month. Unfortunately, despite the strong performance ov
Zhitong A Share Sale Restriction and Release List | April 9
According to the Zhitong Finance App, the ban on restricted shares of 7 listed companies was lifted on April 9, with a total market value of about 5.471 billion yuan. Today's specific sales restrictions and unbanned shares are as follows: Stock abbreviation, stock code, number of shares unbanned, Huabei Pharmaceutical 600812 issued additional A shares, the original shareholder placed 84.256 million shares before issuance, limited sale and circulation 102 million, Jinyu Medical 603882, the original shareholders placed 3.1237 million additional A shares, the original shareholder placed and listed 3.1237 million Yingqu Technology 002925 share incentives to limit circulation 254,200 CCC Radiation 300962 shares restricted circulation before issuance 1.4
CICC Radiation (300962.SZ) Performance Report: Net profit to mother of 108 million yuan in 2023 increased 0.33% year-on-year
Gelonghui, April 8, 丨 CICC Radiation (300962.SZ) announced the 2023 annual results report. During the reporting period, the company achieved total operating revenue of 345 million yuan, an increase of 2.26% over the same period of the previous year; achieved total profit of 128 million yuan, a decrease of 0.05% over the same period of the previous year; realized total profit of 128,156,493.65 yuan, an increase of 0.33% over the same period last year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss 102 million yuan, a year-on-year decrease of 2.
CICC Radiation (300962.SZ): 143 million restricted shares will be listed and circulated from April 9
CICC Radiation (300962.SZ) issued an announcement regarding the listing and circulation of shares issued prior to the initial public offering. This time...
CICC Irradiation (300962.SZ): Theoretically speaking, the company's irradiation technology can be used to treat medical waste and kill pathogenic bacteria and related microorganisms
Gelonghui March 27丨CICC Irradiation (300962.SZ) said on the investor interactive platform that theoretically speaking, the company's irradiation technology can be used to treat medical waste and kill pathogenic bacteria and related microorganisms, but currently the company has not commercialized applications in this field.
China Gold Irradiation (300962.SZ): The cobalt 60 irradiation technology used is a radiation application generated by natural decay of the radioactive isotope cobalt 60, and is not controlled nuclear fusion
Gelonghui, March 27 | CICC Irradiation (300962.SZ) said on the investor interactive platform that the cobalt 60 irradiation technology used by the company is a radiation application generated by natural decay of the radioactive isotope cobalt 60, and is not controlled nuclear fusion.
Medium gold irradiation (300962.SZ): can detect whether the surface of food is radioactive
Gelonghui, March 27 | CICC Irradiation (300962.SZ) said on the investor interactive platform that the company has actively promoted the addition and expansion of technical testing centers (including projects related to nuclear radiation testing). After the additions and expansions are completed, food surfaces can be tested for radioactivity.
Calculating The Fair Value Of Zhongjin Irradiation Incorporated Company (SZSE:300962)
Key Insights The projected fair value for Zhongjin Irradiation is CN¥13.32 based on Dividend Discount Model With CN¥14.91 share price, Zhongjin Irradiation appears to be trading close to its estimat
CICC Radiation (300962.SZ): At present, the company has incorporated market value management into the relevant management assessment index system
Gelonghui, March 21丨CICC Radiation (300962.SZ) said on the investor interactive platform that strengthening market value management is conducive to guiding the company to focus on and strengthen its ability to create value, improve the quality of the company's development, better enhance the company's investment value, and return shareholders and small and medium-sized investors. At present, the company has incorporated market value management into the relevant management assessment index system.
CICC Irradiation (300962.SZ): At present, the company has provided irradiation technical services to prepared food manufacturers
Gelonghui March 18 丨 Some investors asked CICC Irradiation (300962.SZ) on the investor interactive platform, “Does the company provide testing and irradiation sterilization technology for prepared food companies?” The company replied that at present, the company has provided irradiation technology services to prepared food manufacturers.
CICC Irradiation (300962.SZ): Currently, the company has 10 cobalt-60 irradiators and 5 sets of electron accelerators (including 3 under construction)
Gelonghui, March 18: An investor asked CICC Irradiation (300962.SZ) on the investor interactive platform, “Please ask about the proportion of irradiation using cobalt-60 gamma rays and electron accelerators in production.” The company replied that currently the company has 10 cobalt-60 irradiators and 5 sets of electron accelerators (including 3 under construction).
Shenzhen Jinpengyuan, a subsidiary of CICC Irradiation (300962.SZ), will receive about 471 million yuan in relocation compensation
Zhitong Finance App News, CICC Irradiation (300962.SZ) announced that the company's subsidiary Shenzhen Jinpengyuan Irradiation Technology Co., Ltd. (“Shenzhen Jinpengyuan”) reached an agreement with Guangming Street Office and Shenzhen Shenye Mingrui Investment Co., Ltd. on matters related to relocation compensation and resettlement. The three parties intend to sign the “Relocation Compensation and Placement Agreement” and “Supplementary Agreement”, with a total monetary compensation amount of 471 million yuan. The target assets of this transaction are houses, temporary buildings, structures and other attachments within Jinpengyuan Irradiated Industrial Park, No. 11 Baihuayuan Road, Baihua Community, Guangming Street, Guangming District, Shenzhen
CICC Irradiation (300962.SZ): No products related to radiation detection have been produced
Gelonghui March 4 丨 CICC Irradiation (300962.SZ) said on the investor interactive platform that currently the company is equipped with various types of radiation monitoring instruments that can monitor the surface of food for radioactive contamination, and the company has not yet produced products related to radiation testing. The company has planned to add and expand technical testing centers, including projects related to nuclear radiation testing. After completing the addition and expansion and obtaining the corresponding qualifications, it can carry out nuclear radiation testing services such as the surface of items.
Are Robust Financials Driving The Recent Rally In Zhongjin Irradiation Incorporated Company's (SZSE:300962) Stock?
Zhongjin Irradiation's (SZSE:300962) stock is up by a considerable 11% over the past week. Given the company's impressive performance, we decided to study its financial indicators more closely as a
CICC Irradiation (300962.SZ): January 19, 2024, the number of shareholders was 13,874
Gelonghui, January 24, 丨 CICC Radiation (300962.SZ) said on the investor interactive platform that on January 19, 2024, the number of shareholders (consolidated) of the company's top N consolidated ordinary accounts and financial securities lending credit accounts showed that the number of shareholders (consolidated) of the company was 13,874.
CICC Irradiation (300962.SZ): Customer products providing irradiation technical services include animal blood products such as bovine serum
Gelonghui January 10 丨 CICC Irradiation (300962.SZ) said on the investor interactive platform that the company provided irradiation technical services among the customer products provided by the company include animal blood products such as bovine serum.
CICC Radiation (300962.SZ): Expected net profit of RMB 105 million to RMB 116 million in 2023
Gelonghui, January 4, 丨 CICC Radiation (300962.SZ) announced its 2023 annual results forecast. Net profit for 2023 is expected to be 105.06 million yuan to 116.38 million yuan, up -2.48% — 8.03% over the same period of the previous year; profit after deducting non-net profit of 10.5 million yuan to 113.66 million yuan, up -4.51% — 8.00% over the same period last year; basic earnings per share of 0.3979 yuan/share — 0.4408 yuan/share. In 2023, in the face of a complex and changing market environment, the company made every effort to actively promote “big research, excellent layout, rapid development and construction
Some shareholders of CICC Irradiation (300962.SZ) plan to reduce their holdings by no more than 1% in total
CICC Irradiation (300962.SZ) announced that the company's shareholder Gongqingcheng Xinwei Investment Management Partnership (Limited Partnership...
Analysis
Price Target
No Data
